What a great day! We have Spravato (esketamine) in stock. This is the new FDA approved nasal spray for treatment resistant depression. We have used it for years in research, but not we have it for wider use to help more patients. We were excited to move forward so we can help people and in doing so we just found out we were the first in the US to give the approved version of the product to a patient not in a research trial. It went very well, was easy to use and the patient had a good experience. Great news for patients with treatment resistant depression.